We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

111 hedge funds and large institutions have $67.2M invested in Sanofi Contingent Value Rights in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $58.1M → $67.2M (+$9.1M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 120 → 111 (-9)

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

36% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 22

Holders
111
Holders Change
-9
Holders Change %
-7.5%
% of All Funds
2.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
14
Reduced
22
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$588K
2
AFM
Anson Funds Management
Texas
+$543K
3
AMH
Apollo Management Holdings
New York
+$55.3K
4
Wells Fargo
Wells Fargo
California
+$43.9K
5
HCM
Highbridge Capital Management
New York
+$28.7K

Top Sellers

Rank Fund Capital Flow
1
WA
Whitebox Advisors
Minnesota
-$1.76M
2
CLOS
Compagnie Lombard Odier SCmA
Switzerland
-$439K
3
Millennium Management
Millennium Management
New York
-$110K
4
CL
CSS LLC
Illinois
-$91.6K
5
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$79.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teton Advisors
New York
$180K – – –
Wells Fargo
27
Wells Fargo
California
$71K +$43.9K +99,855 +172%
YCM
28
Yakira Capital Management
Connecticut
$70K – – –
First Eagle Investment Management
29
First Eagle Investment Management
New York
$66K – – –
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$57K -$34.3K -78,104 -38%
BCM
31
Basso Capital Management
Connecticut
$56K -$11K -25,000 -17%
Bank of America
32
Bank of America
North Carolina
$53K -$2.97K -6,764 -5%
PAAMCP
33
Pacific Alternative Asset Management Company (PAAMCO)
California
$50K -$66.5K -151,500 -58%
UBS Group
34
UBS Group
Switzerland
$49K +$422 +961 +0.9%
GI
35
GAMCO Investors
Connecticut
$29K – – –
JP Morgan Chase
36
JP Morgan Chase
New York
$27K – – –
OCM
37
Osterweis Capital Management
California
$23K – – –
Korea Investment Corp
38
Korea Investment Corp
South Korea
$22K – – –
Citadel Advisors
39
Citadel Advisors
Florida
$20K -$4.8K -10,927 -20%
ZIG
40
Zuckerman Investment Group
Illinois
$20K -$22 -50 -0.1%
Commonwealth Equity Services
41
Commonwealth Equity Services
Massachusetts
$19K -$247 -563 -1%
DBG
42
De Burlo Group
Massachusetts
$17K – – –
Ameriprise
43
Ameriprise
Minnesota
$16K +$16.2K +36,835 New
CHAM
44
Clear Harbor Asset Management
Connecticut
$15K – – –
Morgan Stanley
45
Morgan Stanley
New York
$14K +$95 +217 +0.7%
FHA
46
Flagship Harbor Advisors
Massachusetts
$12K – – –
SDWMA
47
Schneider Downs Wealth Management Advisors
Pennsylvania
$11K – – –
CS
48
Credit Suisse
Switzerland
$8K – – –
HK
49
Horizon Kinetics
New York
$7K – – –
ISL
50
Ingalls & Snyder LLC
New York
$7K – – –
1
2
3 4

GCVRZ Hedge Fund Activity: Q1 2017 in Review

111 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2017, worth a combined $67.2M — up 16% from $58.1M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of GCVRZ and 8 opened new positions — a net loss of 4 holders — while 22 trimmed existing stakes and 14 added.

The largest buyer was Stonehill Capital Management, adding an estimated $588K. The largest seller was Whitebox Advisors, cutting an estimated $1.76M.

  • 111 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2017, down from 120 in Q4 2016.
  • Funds reported $67.2M of Sanofi Contingent Value Rights stock for Q1 2017, up 16% quarter-over-quarter.
  • 8 funds opened new Sanofi Contingent Value Rights positions in Q1 2017 and 12 closed out, a net change of -4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2017 was Stonehill Capital Management, an estimated $588K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2017 was Whitebox Advisors, an estimated $1.76M sold.

Based on aggregated 13F filings for Q1 2017.